Market Tracker

09/30 5:16pm ET

Boston Scientific Corp (NYSE:BSX)

23.80
Delayed Data
As of Sep 30
 +0.50 / +2.15%
Today’s Change
15.67
Today|||52-Week Range
24.79
+29.07%
Year-to-Date
Boston Scientific to Buy EndoChoice, Boost Endoscopy Line
Sep 30 / Zacks.com - Paid Partner Content
Company News for September 28, 2016
Sep 28 / Zacks.com - Paid Partner Content
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close23.30
Today’s open23.35
Day’s range23.24 - 23.91
Volume8,660,453
Average volume (3 months)9,425,553
Market cap$31.7B
Dividend yield--
Data as of 4:02pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)+18.42%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)+1.25%
P/E ratioNM
Price/Sales3.34
Price/Book4.96

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+3.29+1.86%
ZBHZimmer Biomet Holdin...+2.18+1.71%
BCRC R Bard Inc+0.54+0.24%
DXCMDexCom Inc-0.14-0.16%
Data as of 4:06pm ET, 09/30/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$7.4B
Annual profit (last year)-$239.0M
Net profit margin-3.23%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts